Lantheus Holdings Inc (LNTH) Stock Analysis

Lantheus Holdings Inc (LNTH) is a publicly traded company in the HEALTHCARE sector. It trades at $96.30, carries a market capitalization of $6.32B, a price-to-earnings ratio of 23.18. This page summarizes the public market data, fundamentals, and frequently asked questions for LNTH, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Lantheus Holdings Inc currently has a Bullish sentiment score of 0.38.

About Lantheus Holdings Inc

Lantheus Holdings, Inc. is a prominent biotechnology company headquartered in North Billerica, Massachusetts, specializing in the development, manufacturing, and commercialization of innovative diagnostic and therapeutic agents aimed at treating serious medical conditions, particularly in oncology and cardiology. The company is recognized for its cutting-edge PET imaging agents, which are essential for accurate cancer diagnosis and management, thereby enhancing patient care. Lantheus is commi...

GNG Research Analysis

GNG Research scores Lantheus Holdings Inc (LNTH) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LNTH.

Frequently Asked Questions

Does LNTH pay dividends?

Lantheus Holdings Inc (LNTH) does not currently pay a regular dividend.

What is LNTH's P/E ratio?

Lantheus Holdings Inc has a price-to-earnings (P/E) ratio of 23.18.

What is LNTH's market cap?

Lantheus Holdings Inc (LNTH) has a market capitalization of $6.32B with a current stock price of $96.30.